Shell Asset Management CO Aspira Women'S Health Inc. Transaction History

Shell Asset Management CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$1.63 - $3.43 $39,053 - $82,179	-23,959 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$3.19 - $5.48 $3,030 - $5,206	-950 Reduced 3.81%	23,959 $78,000
Q2 2021 Aug 12, 2021	BUY	$4.78 - $6.84 $119,065 - $170,377	24,909 New	24,909 $140,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.